FORT LAUDERDALE, FL - January 22, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has released an educational

A year prior, the Biden administration gave different reasons for the start of the overdose deaths decline, describing its work to distribute more of the opioid-overdose reversing drug naloxone, increase access to addiction treatment medications and support of harm reduction programs .

Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn’t studying weight loss. Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting that the drug led to significant weight loss in a mid-stage trial.

Share on Pinterest A growing body of evidence suggests that GLP-1 drugs prescribed for obesity and diabetes could also help treat addiction. FreshSplash/Getty Images GLP-1 drugs like Ozempic and Mounjaro are emerging as a potential treatment for alcohol ...

Many jails and prisons around the country don't provide medication treatment for opioid use disorder. Studies show that medication makes recovery more likely and reduces the risk of overdose death.

LOS ANGELES, CA - January 15, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has released

GLP-1s are being studied as ways to help those with addictive tendencies curb those habits.